Business
CYIOS Corp Reports Record $5 Million in Q4 Revenue Through Noir Subsidiary; Noir Full-Year Revenue Exceeds $14.4 Million
CYIOS Corp Reports Record $5 Million in Q4 Revenue Through Noir Subsidiary; Noir Full-Year Revenue Exceeds $14.4 Million.
About this update from Cyios Corp.
[{"type":"text","content":"2024 marks a transformative year for CYIOS Corp, with Noir achieving over 200% year-over-year growth; strategic plans set for continued expansion in 2025. BOCA RATON, FL / ACCESS Newswire / January 16, 2025 / CYIOS Corp (OTC PINK:CYIO) is pleased to announce that its wholly-owned subsidiary, Noir Medical Supplies, delivered a record-breaking $5 million in revenue during Q4 2024. This significant contribution has propelled Noir's full year revenue to over $14.4 million, a substantial increase from $4.55 million in 2023, reflecting over 200% year-over-year growth."2024 was a transformative year for CYIOS," stated Chairman John O'Shea. "The extraordinary success of our Noir acquisition, which closed on August 10th, has not only strengthened our financial position but also set the foundation for a successful 2025."2024 Year in ReviewNoir Acquisition: Completed on August 10, 2024, the acquisition has been instrumental in driving revenue growth.Revenue Milestones:CYIOS Q3 2024 (August 10 - September 30): $2.93 million in revenue.CYIOS Q4 2024: Surpassed $5 million in revenue, marking the highest quarterly revenue in the company's history.Total revenue from Noir post-acquisition (August 10 - December 31): Over $8 million.Noir's full-year 2024 revenue: Surpassed $14.4 million, significantly exceeding initial expectations of $7-$9 million.2025 Roadmap and Strategic FocusCYIOS Corp remains focused on delivering continued revenue growth with a solid foundation firmly in place. Key initiatives for 2025 include:1. Scaling Noir:Expanding product offerings and enhancing geographic reach.Forecasting $15+ million in revenue for Noir in 2025, excluding potential acquisitions.2. Uplisting StrategyCompleting a two-year PCAOB audit to enhance financial transparencyAiming for an exchange uplisting to OTCQB or higherClosing Remarks"CYIOS Corp is well-positioned to build on its momentum from 2024," said O'Shea, Chairman of CYIOS Corp. "We are confident investors will take notice of our new direction, successful execution driving revenue growth and delivering sustainable value for shareholders in 2025 and beyond. By focusing on revenue growth and margin expansion as the cornerstone of our strategy, we aim to create significant long-term shareholder value. With Noir now having completed two quarters under CYIOS, we anti...